Evidence map›Paper›PMID 35273311›Full record

ArticleScientific reports2022

Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study.

David Luque-Paz, Pierre Tattevin, Paul Loubet, François Bénézit, Vincent Thibault, Fabrice Lainé, Philippe Vanhems, Selilah Amour, Bruno Lina, Xavier Duval and 12 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02027233 (Efficiency in Population of Influenza Vaccination for Flu Prevention of the Hospitalized Adults), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02027233 nacompletednot on this map

Efficiency in Population of Influenza Vaccination for Flu Prevention of the Hospitalized Adults

TypeinterventionalSponsorInstitut National de la Santé Et de la Recherche Médicale, FranceRan2014 to 2022Enrolled6,173ConditionsSevere Acute Respiratory InfectionArmsnasopharyngeal sample
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Afebrile Presentation in COPD Patients with Influenza A: A Risk Factor for Prolonged Viral Shedding.International journal of chronic obstructive pulmonary disease · 2026
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 1 country.

David Luque-PazService de Pneumologie, Hôpital Pontchaillou, CHU Rennes, Rennes, France. david.luque.paz@chu-rennes.fr.
Pierre TattevinService de Maladies Infectieuses et Réanimation Médicale, Hôpital Pontchaillou, CHU Rennes, Rennes, France.
Paul LoubetDepartment of Infectious and Tropical Diseases, CHU Nîmes, Univ Montpellier, Nîmes, France.
François BénézitService de Maladies Infectieuses et Réanimation Médicale, Hôpital Pontchaillou, CHU Rennes, Rennes, France.
Vincent ThibaultVirologie, Hôpital Pontchaillou, CHU Rennes, Rennes, France.
Fabrice LainéInserm CIC 1414, CHU Rennes, Rennes, France.
Philippe VanhemsService Hygiène hospitalière, Epidémiologie et Prévention, Hospices Civils de Lyon, Lyon, France.
Selilah AmourService Hygiène hospitalière, Epidémiologie et Prévention, Hospices Civils de Lyon, Lyon, France.
Bruno LinaLaboratoire de Virologie, Institut des Agents Infectieux (IAI), Centre National de Référence des Virus Respiratoires France Sud, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
Xavier DuvalInserm, F-CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France.
Anne-Sophie L'HonneurService de Virologie, Hôpital Cochin, Paris, France.
Nadhira FidouhLaboratoire de Virologie, Hôpital Bichat, AP-HP, Paris, France.
Christine VallejoInserm CIC 1435, CHU Dupuytren, Limoges, France.
Sophie AlainInserm U1092, CHU Limoges, RESINFIT, Limoges, France.
Florence GaltierInserm CIC 1411, Hôpital Saint Eloi, CHU Montpellier, Montpellier, France.
Vincent FoulongneService de Virologie, Hôpital Saint Eloi, CHU Montpellier, Montpellier, France.
Gisèle LagathuVirologie, Hôpital Pontchaillou, CHU Rennes, Rennes, France.
Nezha LenziInserm, F-CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France.
Zineb LesieurInserm, F-CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France.
Odile LaunayInserm, F-CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France.
Stéphane JouneauService de Pneumologie, Hôpital Pontchaillou, CHU Rennes, Rennes, France.
FLUVAC Study Group
Hôpital Bichat-Claude-Bernard · FRCentre Hospitalier Universitaire de Montpellier · FRInserm · FRHôpital Pontchaillou · FRHôpital Cochin · FRHospices Civils de Lyon · FRUniversité Claude Bernard Lyon 1 · FRDélégation Paris 5 · FRHôpital de la Croix-Rousse · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Saint Eloi · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhaled corticosteroids (ICS) have been associated with increased risk of pneumonia. Their impact on respiratory virus infections is unclear. We performed a post-hoc analysis of the FLUVAC cohort, a multicenter prospective cohort study of adults hospitalized with influenza-like illness (ILI) during six consecutive influenza seasons (2012-2018). All patients were tested for respiratory virus infection by multiplex PCR on nasopharyngeal swabs and/or bronchoalveolar lavage. Risk factors were identified by logistic regression analysis. Among the 2658 patients included, 537 (20.2%) were treated with ICS before admission, of whom 282 (52.5%, 282/537) tested positive for at least one respiratory virus. Patients on ICS were more likely to test positive for non-influenza respiratory viruses (25.1% vs. 19.5%, P = 0.004), especially for adenovirus (aOR 2.36, 95% CI 1.18-4.58), and respiratory syncytial virus (aOR 2.08, 95% CI 1.39-3.09). Complications were reported in 55.9% of patients on ICS (300/537), primarily pneumonia (171/535, 32%). Among patients on chronic ICS who tested positive for respiratory virus, 14.2% (40/282) were admitted to intensive care unit, and in-hospital mortality rate was 2.8% (8/282). Chronic use of ICS is associated with an increased risk of adenovirus or RSV infections in patients admitted for ILI.

Indexed as

Influenza, HumanRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsVirus DiseasesVirusesAdrenal Cortex HormonesAdultHumansProspective StudiesAdrenal Cortex Hormones

Identifiers

PMID35273311
PMCPMC8913614
OpenAlexW4221073338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.